FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.
Fusco MJ, Casak SJ, Mushti SL, Cheng J, Christmas BJ, Thompson MD, Fu W, Wang H, Yoon M, Yang Y, Moore JN, Bi Y, Nan Y, Long CE, Auth D, Rahman NA, Tang S, Pazdur R, Fashoyin-Aje LA, Kluetz PG, Lemery SJ.
Fusco MJ, et al. Among authors: thompson md.
Clin Cancer Res. 2024 May 29. doi: 10.1158/1078-0432.CCR-24-0281. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38809262